Lazard Asset Management
PGEN icon

Lazard Asset Management’s Precigen PGEN Stock Holding History

Lazard Asset Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-259
Closed – – 2507
2024
Q4 		$0 Hold
259
– – ﹤0.01% 2466
2024
Q3 		$0 Sell
259
-24,340
-99% -$30.7K ﹤0.01% 2406
2024
Q2 		$38K Sell
24,599
-9,879
-29% -$14.3K ﹤0.01% 1971
2024
Q1 		$49K Sell
34,478
-5,879
-15% -$8.44K ﹤0.01% 1717
2023
Q4 		$53K Sell
40,357
-1,480
-4% -$1.74K ﹤0.01% 1873
2023
Q3 		$58K Buy
41,837
+27,067
+183% +$38.4K ﹤0.01% 1812
2023
Q2 		$16K Buy
14,770
+50
+0.3% +$59 ﹤0.01% 2142
2023
Q1 		$15K Sell
14,720
-30,229
-67% -$43.6K ﹤0.01% 2096
2022
Q4 		$68K Buy
+44,949
New +$77.3K ﹤0.01% 1674
2015
Q2 		– Sell
-2,480
Closed -$107K – 1165
2015
Q1 		$107K Sell
2,480
-39,269
-94% -$1.41M ﹤0.01% 911
2014
Q4 		$1.1M Buy
+41,749
New +$915K ﹤0.01% 750
2014
Q3 		– Sell
-151,197
Closed -$3.63M – 1086
2014
Q2 		$3.63M Sell
151,197
-4,922
-3% -$99.8K 0.01% 570
2014
Q1 		$3.92M Sell
156,119
-176,368
-53% -$4.88M 0.01% 520
2013
Q4 		$7.56M Buy
332,487
+5,437
+2% +$110K 0.02% 430
2013
Q3 		$7.4M Buy
+327,050
New +$7.55M 0.02% 424

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Lazard Asset Management's PGEN Position: Q1 2025 in Review

Lazard Asset Management sold out of Precigen (PGEN) in Q1 2025, closing a stake of 259 shares.

Lazard Asset Management first reported a position in PGEN in Q3 2013 and held it in 15 quarters. The position peaked at $7.56M in Q4 2013. 138 funds tracked by Wall St. Rank hold PGEN as of Q1 2025.

  • Lazard Asset Management reported no remaining Precigen position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 259 Precigen shares in Q1 2025.
  • Lazard Asset Management first reported a position in Precigen in Q3 2013 and held it in 15 quarters.
  • Lazard Asset Management's Precigen position peaked at $7.56M in Q4 2013.
  • 138 funds tracked by Wall St. Rank held Precigen as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.